Allogenic Adipose-Tissue-Derived Mesenchymal Stem Cells

5 trials 2 recruiting

Filter these 5 trials by condition, phase, country and more.

Open in Search →

5 Registered trials

2 Recruiting

1 Completed trials

3 Sponsors

3 Countries

Phase II

Phase I (Other)

Phase II: 4 Phase I (Other): 1

Indications tested

Autism spectrum disorder 1

Sponsors using this IMP

Cell2cure ApS 2 Centre Hospitalier Universitaire De Nantes 2 Medical University Of Warsaw 1

All trials

5 total

An open label safety and efficacy study of allogenic adipose tissue-derived mesenchymal stromal cells on autism and gastrointestinal symptom… Not authorised

2025-523699-21-00 Phase I (Other) 1 country Cell to Cure ApS
Efficacy and safety of allogenic cultured Adipose-derived mesenchymal stromal cell injections on MoUth fibrosis and handicap in patients wit… Pending

2024-518516-39-00 Phase II 1 country Centre Hospitalier Universitaire De Toulouse
Evaluation of the safety and efficacy of an advanced therapy medicinal product containing live ASCs in the treatment of diabetic foot syndro… Recruiting

2024-518533-29-00 Phase II 1 country Medical University Of Warsaw
SUBCUTANEOUS INJECTIONS OF AUTOLOGOUS CULTURED ADIPOSE-DERIVED STROMA/ STEM CELLS TO HEAL REFRACTORY ISCHEMIC DIGITAL ULCERS IN PATIENTS WIT… Recruiting

2023-508432-53-00 Phase II 1 country Centre Hospitalier Universitaire De Toulouse
ARIISE - ASCs in recently diagnosed non-ischemic heart failure Ended

2025-520837-22-00 Phase II 1 country Cell2Cure ApS

Showing 1–5 of 5 trials

← All drugs A–Z